Podcast 2: Future Management of Patients with Oesophageal Cancer

This content has been funded by Novartis, the position and discussions might not represent the position of Novartis. The content was intended for non-USA and non-UK healthcare professionals.

This EMG Health podcast kicks off with Bridget Scott introducing two experts, David Ilson, Medical Oncologist, Memorial Sloan Kettering Cancer Center, Gastrointestinal Oncology, New York, USA, and Samuel Klempner, Associate Professor, Massachusetts General Hospital, Harvard Medical School, USA, who discuss critical unmet needs in the management of patients with oesophageal cancer.